Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats

Journal of Physiology

Volumn 595, Issue 8, 2017, Pages 2479-2495

  Toledo, Camilo ^a   Andrade, David C ^a   Lucero, Claudia ^a   Arce Alvarez, Alexis ^a   Díaz, Hugo S ^a   Aliaga, Valentín ^a   Schultz, Harold D ^b   Marcus, Noah J ^c   Manríquez, Mónica ^a   Faúndez, Marcelo ^a   Del Rio, Rodrigo ^a  

^a UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c DES MOINES UNIVERSITY   (United States)

Author keywords

autonomic imbalance; cardiac function; central chemoreflex; heart failure preserved ejection fraction; respiratory disorders

Indexed keywords

PROPRANOLOL;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APNEA HYPOPNEA INDEX; ARRHYTHMOGENESIS; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN STEM; BREATHING; CELL ACTIVATION; CHEMORECEPTOR REFLEX; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE EXACERBATION; HEART ARRHYTHMIA; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART RATE VARIABILITY; HYPERCAPNIA; INCIDENCE; MALE; NERVE CELL; NONHUMAN; RAT; REST; SPRAGUE DAWLEY RAT; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; VAGUS TONE; ANIMAL; CHEMORECEPTOR CELL; DIASTOLE; HEART FAILURE; HEART RATE; HEART STROKE VOLUME; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ARRHYTHMIAS, CARDIAC; CHEMORECEPTOR CELLS; DIASTOLE; HEART FAILURE; HEART RATE; HYPERCAPNIA; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; STROKE VOLUME;

EID: 85016405099     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP273558     Document Type: Article

References (60)

1. Abassi Z, Goltsman I, Karram T, Winaver J & Hoffman A (2011). Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy. J Biomed Biotechnol 2011, 729497.
2. Abbott SB, DePuy SD, Nguyen T, Coates MB, Stornetta RL & Guyenet PG (2013). Selective optogenetic activation of rostral ventrolateral medullary catecholaminergic neurons produces cardiorespiratory stimulation in conscious mice. J Neurosci 33, 3164–3177.
3. Aboukhalil A, Nielsen L, Saeed M, Mark RG & Clifford GD (2008). Reducing false alarm rates for critical arrhythmias using the arterial blood pressure waveform. J Biomed Inform 41, 442–451.
4. Andrade DC, Lucero C, Toledo C, Madrid C, Marcus NJ, Schultz HD & Del Rio R (2015). Relevance of the carotid body chemoreflex in the progression of heart failure. Biomed Res 2015, 467597.
5. Banes AK, Shaw SM, Tawfik A, Patel BP, Ogbi S, Fulton D & Marrero MB (2005). Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin. Am J Physiol Cell Physiol 288, C805–812.
6. Bitter T, Faber L, Hering D, Langer C, Horstkotte D & Oldenburg O (2009). Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail 11, 602–608.
7. 2. J Physiol 588, 2455–2471.
8. Borlaug BA & Kass DA (2006). Mechanisms of diastolic dysfunction in heart failure. Trends Cardiovasc Med 16, 273–279.
9. Brodsky S, Gurbanov K, Abassi Z, Hoffman A, Ruffolo RR Jr, Feuerstein GZ & Winaver J (1998). Effects of eprosartan on renal function and cardiac hypertrophy in rats with experimental heart failure. Hypertension 32, 746–752.
10. Cingolani OH & Kass DA (2011). Pressure–volume relation analysis of mouse ventricular function. Am J Physiol Heart Circ Physiol 301, H2198–2206.
11. Cingolani OH, Yang XP, Liu YH, Villanueva M, Rhaleb NE & Carretero OA (2004). Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats. Hypertension 43, 1067–1073.
12. Chan MM & Lam CS (2013). How do patients with heart failure with preserved ejection fraction die? Eur J Heart Fail 15, 604–613.
13. Del Rio R, Andrade DC, Lucero C, Arias P & Iturriaga R (2016). Carotid body ablation abrogates hypertension and autonomic alterations induced by intermittent hypoxia in rats. Hypertension 68, 436–445.
14. Del Rio R, Marcus NJ & Schultz HD (2013). Carotid chemoreceptor ablation improves survival in heart failure: rescuing autonomic control of cardiorespiratory function. J Am Coll Cardiol 62, 2422–2430.
15. Ding Y, Li YL, Zimmerman MC, Davisson RL & Schultz HD (2009). Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits. Cardiovasc Res 81, 678–685.
16. Edelmann F, Stahrenberg R, Gelbrich G,Durstewitz K, Angermann CE, Düngen H-D, Scheffold T, Zugck C, Maisch B, Regitz-Zagrosek V, Hasenfuß G, Pieske BM & Wachter R (2011). Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol 100, 755–764.
17. Esler M (1998). High blood pressure management: potential benefits of I1 agents. J Hypertens Suppl 16, S19–24.
18. Florea VG & Cohn JN (2014). The autonomic nervous system and heart failure. Circ Res 114, 1815–1826.
19. Giannoni A, Emdin M, Bramanti F, Iudice G, Francis DP, Barsotti A, Piepoli M & Passino C (2009). Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. J Am Coll Cardiol 53, 1975–1980.
20. Giannoni A, Emdin M, Poletti R, Bramanti F, Prontera C, Piepoli M & Passino C (2008). Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. Clin Sci 114, 489–497.
21. Grundy D (2015). Principles and standards for reporting animal experiments in The Journal of Physiology and Experimental Physiology. J Physiol 593, 2547–2549.
22. Guyenet PG (2014). Regulation of breathing and autonomic outflows by chemoreceptors. Compr Physiol 4, 1511–1562.
23. Guyenet PG & Mulkey DK (2010). Retrotrapezoid nucleus and parafacial respiratory group. Respir Physiol Neurobiol 173, 244–255.
24. Guyenet PG, Mulkey DK, Stornetta RL & Bayliss DA (2005). Regulation of ventral surface chemoreceptors by the central respiratory pattern generator. J Neurosci 25, 8938–8947.
25. 2 chemoreception and integrated neural mechanisms of cardiovascular and respiratory control. J Appl Phys 108, 995–1002.
26. Haack KK, Engler CW, Papoutsi E, Pipinos II, Patel KP & Zucker IH (2012). Parallel changes in neuronal AT1R and GRK5 expression following exercise training in heart failure. Hypertension 60, 354–361.
27. Haack KK, Marcus NJ, Del Rio R, Zucker IH & Schultz HD (2014). Simvastatin treatment attenuates increased respiratory variability and apnea/hypopnea index in rats with chronic heart failure. Hypertension 63, 1041–1049.
28. Hamdani N, Franssen C, Lourenco A, Falcao-Pires I, Fontoura D, Leite S, Plettig L, Lopez B, Ottenheijm CA, Becher PM, Gonzalez A, Tschope C, Diez J, Linke WA, Leite-Moreira AF & Paulus WJ (2013). Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model. Circ Heart Fail 6, 1239–1249.
29. Herrscher TE, Akre H, Overland B, Sandvik L & Westheim AS (2011). High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail 17, 420–425.
30. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM & Stewart KP (2002). Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288, 2144–2150.
31. Kristen AV, Just A, Haass M & Seller H (2002). Central hypercapnic chemoreflex modulation of renal sympathetic nerve activity in experimental heart failure. Basic Res Cardiol 97, 177–186.
32. Lafon-Cazal M, Pietri S, Culcasi M & Bockaert J (1993). NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535–537.
33. Lazarenko RM, Milner TA, Depuy SD, Stornetta RL, West GH, Kievits JA, Bayliss DA & Guyenet PG (2009). Acid sensitivity and ultrastructure of the retrotrapezoid nucleus in Phox2b-EGFP transgenic mice. J Comp Neurol 517, 69–86.
34. Leite S, Rodrigues S, Tavares-Silva M, Oliveira-Pinto J, Alaa M, Abdellatif M, Fontoura D, Falcao-Pires I, Gillebert TC, Leite-Moreira AF & Lourenco AP (2015). Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol 309, H1648–1654.
35. Lorenzi-Filho G, Rankin F, Bies I & Douglas Bradley T (1999). Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159, 1490–1498.
36. Lindley TE, Doobay MF, Sharma RV & Davisson RL (2004). Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res 94, 402–409.
37. Mansukhani MP, Kara T, Caples SM & Somers VK (2014). Chemoreflexes, sleep apnea, and sympathetic dysregulation. Curr Hypertens Rep 16, 476.
38. Marcus NJ, Del Rio R, Schultz EP, Xia XH & Schultz HD (2014a). Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure. J Physiol 592, 391–408.
39. Marcus NJ, Del Rio R & Schultz HD (2014b). Central role of carotid body chemoreceptors in disordered breathing and cardiorenal dysfunction in chronic heart failure. Front Physiol 5, 438.
40. Modesti PA, Vanni S, Bertolozzi I, Cecioni I, Lumachi C, Perna AM, Boddi M & Gensini GF (2004). Different growth factor activation in the right and left ventricles in experimental volume overload. Hypertension 43, 101–108.
41. Moreira TS, Takakura AC, Colombari E & Guyenet PG (2006). Central chemoreceptors and sympathetic vasomotor outflow. J Physiol 577, 369–386.
42. Narkiewicz K, Pesek CA, van de Borne PJ, Kato M & Somers VK (1999). Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 100, 262–267.
43. Oktay AA, Rich JD & Shah SJ (2013). The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep 10, 401–410.
44. Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D & Topfer V (2007). Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9, 251–257.
45. Oliveira-Sales EB, Colombari DS, Davisson RL, Kasparov S, Hirata AE, Campos RR & Paton JF (2010). Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension 56, 290–296.
46. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL & Redfield MM (2006). Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355, 251–259.
47. Pacher P, Nagayama T, Mukhopadhyay P, Batkai S & Kass DA (2008). Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats. Nat Protoc 3, 1422–1434.
48. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S & Piccaluga E (1986). Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59, 178–193.
49. Palkovits M (1983). Punch sampling biopsy technique. Methods Enzymol 103, 368–376.
50. Paxinos G, Watson CR & Emson PC (1980). AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods 3, 129–149.
51. Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb-Peploe K, Harrington D, Anker SD, Volterrani M, Colombo R, Mazzuero G, Giordano A & Coats AJ (1997). Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96, 2586–2594.
52. Rommel KP, von Roeder M, Latuscynski K, Oberueck C, Blazek S, Fengler K, Besler C, Sandri M, Lucke C, Gutberlet M, Linke A, Schuler G & Lurz P (2016). Extracellular volume fraction for characterization of patients with heart failure and preserved ejection fraction. J Am Coll Cardiol 67, 1815–1825.
53. Rosin DL, Chang DA & Guyenet PG (2006). Afferent and efferent connections of the rat retrotrapezoid nucleus. J Comp Neurol 499, 64–89.
54. Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, Lucchesi PA & Dell'Italia LJ (2007). Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 49, 811–821.
55. Rosita Z, Borlaug BA, McNulty SE, Mohammed SF, Lewis GD, Semigran MJ, Deswal A, LeWinter M, Hernandez AF, Braunwald E, Redfield MM (2014). Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: clinical perspective. Circ Heart Fail 7, 123–130.
56. Toischer K, Rokita AG, Unsold B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lehnart SE, Kruger M, Linke WA, Backs J, Regitz-Zagrosek V, Schafer K, Field LJ, Maier LS & Hasenfuss G (2010). Differential cardiac remodeling in preload versus afterload. Circulation 122, 993–1003.
57. Toledo C, Andrade DC, Lucero C, Schultz HD, Marcus N, Retamal M, Madrid C & Del Rio R (2016). Contribution of peripheral and central chemoreceptors to sympatho-excitation in heart failure. J Physiol 2016, 1–9.
58. Vesce S, Kirk L & Nicholls DG (2004). Relationships between superoxide levels and delayed calcium deregulation in cultured cerebellar granule cells exposed continuously to glutamate. J Neurochem 90, 683–693.
59. 2. J Neurosci 33, 7756–7761.
60. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ & Wilkoff BL, American College of Cardiology F & American Heart Association Task Force on Practice G (2013). 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62, e147–239.